451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19?

BACKGROUND: Virus-specific antibodies help to understand the prevalence of infections and the course of the immune response. Humans produce antibodies against the spike and nucleocapsid proteins of SARS-COV-2 virus. Patients with COVID-19 who recover from the infections have higher levels of antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Hemang, Bhargava, Ashish, Lebovic, Daniel, Scarabelli, Tiziano, Coyle, Meredith M, Salaytah, Natali, Saravolatz, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643798/
http://dx.doi.org/10.1093/ofid/ofab466.650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643798/
http://dx.doi.org/10.1093/ofid/ofab466.650

Ejemplares similares